CSPC Pharmaceutical Group Limited

(PINK:CSPCY)

Latest On CSPC Pharmaceutical Group Limited (CSPCY):

Date/Time Type Description Signal Details
2023-09-07 05:59 ESTDividendA dividend of $0.07 has been announced on Aug 23, 2023. It will be paid Oct 26, 2023 with an ex-dividend date of Sep 7, 2023.Neutral
2023-06-05 05:59 ESTDividendA dividend of $0.06 has been announced on Mar 22, 2023. It will be paid Jul 13, 2023 with an ex-dividend date of Jun 5, 2023.Neutral
2023-03-29 21:38 ESTNewsCSPC Pharma Wins China's mRNA Vaccine Race, But Just Not Fast EnoughN/A
2023-03-22 20:43 ESTNewsChina approves emergency use of 1st home-grown mRNA COVID vaccineN/A
2022-09-08 05:59 ESTDividendA dividend of $0.05 has been announced on Aug 24, 2022. It will be paid Oct 25, 2022 with an ex-dividend date of Sep 8, 2022.Neutral
2022-05-31 05:59 ESTDividendA dividend of $0.05 has been announced on Apr 1, 2022. It will be paid Jul 7, 2022 with an ex-dividend date of May 31, 2022.Neutral
2022-04-04 10:38 ESTNewsCanSino, CSPC Pharma win regulatory nod in China to start trials for mRNA COVID-19 shotsN/A
2021-09-10 05:59 ESTDividendA dividend of $0.04 has been announced on Aug 26, 2021. It will be paid Oct 25, 2021 with an ex-dividend date of Sep 10, 2021.Neutral
2021-05-24 06:01 ESTDividendA dividend of $0.05 has been announced on Mar 16, 2021. It will be paid Jun 25, 2021 with an ex-dividend date of May 24, 2021.Neutral
2020-11-26 22:47 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:12 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 15:05 ESTFinancialsCompany financials have been released.Neutral
2020-09-19 18:43 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:11 ESTFinancialsCompany financials have been released.Neutral
2020-09-09 06:01 ESTDividendA dividend of $0.03 has been announced on Aug 26, 2020. It will be paid Jan 1, 1970 with an ex-dividend date of Sep 9, 2020.Neutral
2020-08-14 11:06 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 14:42 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:51 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 23:02 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:43 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:25 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:32 ESTFinancialsCompany financials have been released.Neutral
2020-06-18 05:59 ESTDividendA dividend of $0.1 has been announced on May 22, 2020. It will be paid Jul 17, 2020 with an ex-dividend date of Jun 18, 2020.Neutral
2020-06-14 06:38 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:14 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 07:15 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:49 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 07:29 ESTFinancialsCompany financials have been released.Neutral
2020-05-04 14:29 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:27 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 06:33 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 06:15 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 22:20 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 22:19 ESTFinancialsCompany financials have been released.Neutral
2020-04-04 06:01 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 22:49 ESTFinancialsCompany financials have been released.Neutral
2020-03-25 22:21 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 05:54 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 23:58 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:31 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 01:00 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 01:17 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 01:31 ESTFinancialsCompany financials have been released.Neutral

About CSPC Pharmaceutical Group Limited (CSPCY):

See Advanced Chart

General

  • Name CSPC Pharmaceutical Group Limited
  • Symbol CSPCY
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorOther
  • IndustryOther
  • Fiscal Year EndDecember
View More

Valuation

  • Trailing PE 13.41
  • Forward PE 20.75
  • Price/Sales (Trailing 12 Mt.) 3.76
  • Price/Book (Most Recent Quarter) 7.1
  • Enterprise Value Revenue 0.59
  • Enterprise Value EBITDA 2.65
View More

Financials

  • Most Recent Quarter 2017-12-31
  • Revenue Per Share $0
  • Gross Profit 9.35 billion
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 7.72 billion
  • PEG Ratio 2.31
View More

Share Statistics

  • % Held by Insiders <1%
View More

Technicals

  • 52 Week High $5.55
  • 52 Week Low $2.51
  • 50 Day Moving Average 4.39
  • 200 Day Moving Average 4.12
View More

Dividends

  • Forward Annual Dividend Yield 1.3%
  • Dividend Date 2020-10-26
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

CSPC Pharmaceutical Group Limited (CSPCY) Dividend Calendar:

CSPCY's last dividend payment was made to shareholders on October 26, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

CSPC Pharmaceutical Group Limited (CSPCY) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Jun 30 2019 Dec 31 2017 Sep 30 2017 Jun 30 2017 Mar 31 2017
Research Development N/A N/A N/A N/A N/A
Income Before Tax N/A 887.53 million 912.51 million 859.47 million 805.79 million
Selling General Administrative N/A 1.56 billion 1.33 billion 1.13 billion 1.03 billion
Gross Profit N/A 2.79 billion 2.43 billion 2.15 billion 1.98 billion
Ebit N/A 901.51 million 916.95 million 876.24 million 806.89 million
Operating Income N/A 901.51 million 916.95 million 876.24 million 806.89 million
Income Tax Expense N/A 159.38 million 179.25 million 181.66 million 164.95 million
Total Revenue N/A 4.25 billion 4.01 billion 3.73 billion 3.47 billion
Cost of Revenue N/A 1.46 billion 1.58 billion 1.58 billion 1.49 billion
Total Other Income Expense Net N/A -13.99 million -4.44 million -16.77 million -1.1 million
Net Income From Continuing Operations N/A 728.15 million 733.26 million 677.81 million 640.83 million
Net Income Applicable to Common Shares N/A 726.82 million 730.77 million 675.05 million 637.88 million
Balance Sheet:
Date Jun 30 2020 Dec 31 2019 Jun 30 2019 Dec 31 2017 Sep 30 2017
Total Liabailities 8.46 billion 6.8 billion 6.81 billion 6.14 billion N/A
Total Stockholder Equity 19.97 billion 18.46 billion 16.47 billion 15.32 billion 11.05 billion
Other Current Liabilities N/A N/A N/A 2.43 billion N/A
Total Assets 29.17 billion 26.32 billion 24.32 billion 21.54 billion N/A
Common Stock N/A N/A N/A 12.92 billion N/A
Other Current Assets N/A N/A N/A 274.98 million N/A
Retained Earnings N/A N/A N/A N/A N/A
Other Liabilities N/A N/A N/A 315.58 million N/A
Other Assets N/A N/A N/A 593.8 million N/A
Cash 5.95 billion 4.12 billion 4.03 billion 5.24 billion N/A
Total Current Liabilities 7.9 billion 6.24 billion 6.14 billion 5.76 billion N/A
Other Stockholder Equity N/A N/A N/A 2.4 billion N/A
Property, Plant & Equipment N/A N/A N/A 6.66 billion N/A
Total Current Assets 16.49 billion 13.7 billion 13.04 billion 13.63 billion N/A
Long Term Investments N/A N/A N/A 426.72 million N/A
Net Tangible Assets N/A N/A N/A 15.1 billion 10.8 billion
Short Term Investments 387000 536000 533000 1.32 billion N/A
Long Term Debt N/A N/A N/A 59.81 million N/A
Inventory 2.1 billion 2.54 billion 2.47 billion 2.9 billion N/A
Accounts Payable 1.57 billion 1.43 billion 2.28 billion 1.55 billion N/A

CSPC Pharmaceutical Group Limited (CSPCY) Chart:

CSPC Pharmaceutical Group Limited (CSPCY) News:

Below you will find a list of latest news for CSPC Pharmaceutical Group Limited (CSPCY) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

CSPC Pharmaceutical Group Limited (CSPCY) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

CSPC Pharmaceutical Group Limited (CSPCY) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link